294 related articles for article (PubMed ID: 8470429)
1. Serological correlates in whooping cough.
Granström M; Granström G
Vaccine; 1993; 11(4):445-8. PubMed ID: 8470429
[TBL] [Abstract][Full Text] [Related]
2. Serum IgG antibody response to pertussis toxin in persons for whom pertussis vaccination failed depends upon the number of antigens in the vaccine.
Cherry JD
Clin Infect Dis; 1999 Mar; 28(3):560-1. PubMed ID: 10194078
[No Abstract] [Full Text] [Related]
3. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
[TBL] [Abstract][Full Text] [Related]
4. Household contact study of Bordetella pertussis infections.
Deen JL; Mink CA; Cherry JD; Christenson PD; Pineda EF; Lewis K; Blumberg DA; Ross LA
Clin Infect Dis; 1995 Nov; 21(5):1211-9. PubMed ID: 8589145
[TBL] [Abstract][Full Text] [Related]
5. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M
Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215
[TBL] [Abstract][Full Text] [Related]
6. [Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. II. Occurence and level of B. pertussis antigens in children with suspected whooping cough].
Chodorowska M
Med Dosw Mikrobiol; 1999; 51(3-4):269-80. PubMed ID: 10803256
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
Winsnes R; Lønnes T; Møgster B; Berdal BP
Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
[TBL] [Abstract][Full Text] [Related]
8. History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin.
Zackrisson G; Taranger J; Trollfors B
J Pediatr; 1990 Feb; 116(2):190-4. PubMed ID: 2299488
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to filamentous hemagglutinin of Bordetella pertussis and protection against whooping cough in schoolchildren.
He Q; Viljanen MK; Olander RM; Bogaerts H; De Grave D; Ruuskanen O; Mertsola J
J Infect Dis; 1994 Sep; 170(3):705-8. PubMed ID: 8077734
[TBL] [Abstract][Full Text] [Related]
10. Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis.
Isacson J; Trollfors B; Hedvall G; Taranger J; Zackrisson G
Scand J Infect Dis; 1995; 27(3):273-7. PubMed ID: 8539553
[TBL] [Abstract][Full Text] [Related]
11. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin.
Cahill ES; O'Hagan DT; Illum L; Redhead K
FEMS Microbiol Lett; 1993 Mar; 107(2-3):211-6. PubMed ID: 8472903
[TBL] [Abstract][Full Text] [Related]
12. [Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. I. Antibody level for B pertussis antigens in children without respiratory tract infection symptoms].
Chodorowska M
Med Dosw Mikrobiol; 1999; 51(3-4):259-68. PubMed ID: 10803255
[TBL] [Abstract][Full Text] [Related]
13. Effect of erythromycin treatment on antibody responses in pertussis.
Granström G; Granström M
Scand J Infect Dis; 1994; 26(4):453-7. PubMed ID: 7984978
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of transplacental transmission of pertussis antibodies in premature and full-term infants.
Nomura M; Kuno-Sakai H; Kimura M; Ichikawa I
Tokai J Exp Clin Med; 2003 Apr; 28(1):21-6. PubMed ID: 12880300
[No Abstract] [Full Text] [Related]
15. Binding of murine antibodies against whole-cell pertussis vaccine or filamentous haemagglutinin by Bordetella pertussis from patients with whooping cough.
van den Berg BM; Beekhuizen H; Van Furth R; Mooi FR
Scand J Immunol; 2000 May; 51(5):530-2. PubMed ID: 10792847
[TBL] [Abstract][Full Text] [Related]
16. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.
Storsaeter J; Hallander HO; Gustafsson L; Olin P
Vaccine; 1998 Dec; 16(20):1907-16. PubMed ID: 9796042
[TBL] [Abstract][Full Text] [Related]
17. Distribution of pertussis antibodies among different age groups in Japan.
Konda T; Kamachi K; Iwaki M; Matsunaga Y
Vaccine; 2002 Mar; 20(13-14):1711-7. PubMed ID: 11906757
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children.
Podda A; Carapella De Luca E; Titone L; Casadei AM; Cascio A; Bartalini M; Volpini G; Peppoloni S; Marsili I; Nencioni L
J Pediatr; 1993 Jul; 123(1):81-4. PubMed ID: 8320630
[TBL] [Abstract][Full Text] [Related]
19. Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents.
Hodder SL; Cherry JD; Mortimer EA; Ford AB; Gornbein J; Papp K
Clin Infect Dis; 2000 Jul; 31(1):7-14. PubMed ID: 10913389
[TBL] [Abstract][Full Text] [Related]
20. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.
Cherry JD; Gornbein J; Heininger U; Stehr K
Vaccine; 1998 Dec; 16(20):1901-6. PubMed ID: 9796041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
